Home/Filings/4/0001453687-25-000068
4//SEC Filing

English Emily 4

Accession 0001453687-25-000068

CIK 0001453687other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 4:35 PM ET

Size

7.2 KB

Accession

0001453687-25-000068

Insider Transaction Report

Form 4
Period: 2025-04-15
English Emily
Chief Operations Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-15$3.30/sh+7,500$24,75047,726 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-04-157,50041,869 total
    Exercise: $3.30Exp: 2031-04-25Common Stock (7,500 underlying)
Footnotes (2)
  • [F1]These options are currently fully vested and exercisable.
  • [F2]On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0002019791

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:35 PM ET
Size
7.2 KB